RTOG 0525: A randomized phase III trial comparing standard adjuvant temozolomide (TMZ) with a dose-dense (dd) schedule in newly diagnosed glioblastoma (GBM).

M. R. Gilbert; M. Wang; K. D. Aldape; R. Stupp; M. Hegi; K. A. Jaeckle; T. S. Armstrong; J. S. Wefel; M. Won; D. T. Blumenthal; A. Mahajan; C. J. Schultz; S. C. Erridge; P. D. Brown; A. Chakravarti; W. J. Curran; M. P. Mehta

doi:10.1200/jco.2011.29.15_suppl.2006

RTOG 0525: A randomized phase III trial comparing standard adjuvant temozolomide (TMZ) with a dose-dense (dd) schedule in newly diagnosed glioblastoma (GBM).

M. R. Gilbert, M. Wang, K. D. Aldape, R. Stupp, M. Hegi, K. A. Jaeckle, T. S. Armstrong, J. S. Wefel, M. Won, D. T. Blumenthal, A. Mahajan, C. J. Schultz, S. C. Erridge, P. D. Brown, A. Chakravarti, W. J. Curran, M. P. Mehta

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Clinical Oncology
Volume	29
DOIs	https://doi.org/10.1200/jco.2011.29.15_suppl.2006
State	Published - May 20 2011

Disciplines

Physical Therapy
Medicine and Health Sciences
Pathology

Access to Document

10.1200/jco.2011.29.15_suppl.2006License: Unspecified

Cite this

Gilbert, M. R., Wang, M., Aldape, K. D., Stupp, R., Hegi, M., Jaeckle, K. A., Armstrong, T. S., Wefel, J. S., Won, M., Blumenthal, D. T., Mahajan, A., Schultz, C. J., Erridge, S. C., Brown, P. D., Chakravarti, A., Curran, W. J., & Mehta, M. P. (2011). RTOG 0525: A randomized phase III trial comparing standard adjuvant temozolomide (TMZ) with a dose-dense (dd) schedule in newly diagnosed glioblastoma (GBM). Journal of Clinical Oncology, 29. https://doi.org/10.1200/jco.2011.29.15_suppl.2006

Gilbert, MR, Wang, M, Aldape, KD, Stupp, R, Hegi, M, Jaeckle, KA, Armstrong, TS, Wefel, JS, Won, M, Blumenthal, DT, Mahajan, A, Schultz, CJ, Erridge, SC, Brown, PD, Chakravarti, A, Curran, WJ & Mehta, MP 2011, 'RTOG 0525: A randomized phase III trial comparing standard adjuvant temozolomide (TMZ) with a dose-dense (dd) schedule in newly diagnosed glioblastoma (GBM).', Journal of Clinical Oncology, vol. 29. https://doi.org/10.1200/jco.2011.29.15_suppl.2006

@article{c2b7ab7a7d924e95b4df1ebaa2a84d0a,

title = "RTOG 0525: A randomized phase III trial comparing standard adjuvant temozolomide (TMZ) with a dose-dense (dd) schedule in newly diagnosed glioblastoma (GBM).",

author = "Gilbert, \{M. R.\} and M. Wang and Aldape, \{K. D.\} and R. Stupp and M. Hegi and Jaeckle, \{K. A.\} and Armstrong, \{T. S.\} and Wefel, \{J. S.\} and M. Won and Blumenthal, \{D. T.\} and A. Mahajan and Schultz, \{C. J.\} and Erridge, \{S. C.\} and Brown, \{P. D.\} and A. Chakravarti and Curran, \{W. J.\} and Mehta, \{M. P.\}",

note = "In order to access this website, please configure your browser to support cookies.",

year = "2011",

month = may,

day = "20",

doi = "10.1200/jco.2011.29.15\_suppl.2006",

language = "American English",

volume = "29",

journal = "Journal of Clinical Oncology",

}

TY - JOUR

T1 - RTOG 0525: A randomized phase III trial comparing standard adjuvant temozolomide (TMZ) with a dose-dense (dd) schedule in newly diagnosed glioblastoma (GBM).

AU - Gilbert, M. R.

AU - Wang, M.

AU - Aldape, K. D.

AU - Stupp, R.

AU - Hegi, M.

AU - Jaeckle, K. A.

AU - Armstrong, T. S.

AU - Wefel, J. S.

AU - Won, M.

AU - Blumenthal, D. T.

AU - Mahajan, A.

AU - Schultz, C. J.

AU - Erridge, S. C.

AU - Brown, P. D.

AU - Chakravarti, A.

AU - Curran, W. J.

AU - Mehta, M. P.

N1 - In order to access this website, please configure your browser to support cookies.

PY - 2011/5/20

Y1 - 2011/5/20

UR - http://ascopubs.org/doi/abs/10.1200/jco.2011.29.15_suppl.2006

U2 - 10.1200/jco.2011.29.15_suppl.2006

DO - 10.1200/jco.2011.29.15_suppl.2006

M3 - Article

VL - 29

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -

RTOG 0525: A randomized phase III trial comparing standard adjuvant temozolomide (TMZ) with a dose-dense (dd) schedule in newly diagnosed glioblastoma (GBM).

Disciplines

Access to Document

Other files and links

Cite this